Department of Clinical Nutrition, Erciyes University, Turkey.
Department of Hematology, Erciyes University, Turkey.
Clin Nutr ESPEN. 2022 Oct;51:385-390. doi: 10.1016/j.clnesp.2022.07.014. Epub 2022 Aug 6.
Refeeding Hypophosphatemia (RH) occurs with feeding after an extended period of not feeding. Hematological Stem Cell Transplantation (HSCT) is one of the effective methods for hematologic malignancy. Nutritional disorders are frequently observed in hematologic malignancies due to the disease's pathology and the treatment's effect. The study aims to determine the influencing factors by determining the frequency of RH in patients treated with HSCT.
The study was conducted prospectively and randomly with 50 patients treated with HSCT for the first time. The study followed patients for 22 days, seven days before, and 14 days after. During the follow-up, data such as Scored Patient-Generated Subjective Global Assessment (PG-SGA), weight changes, nausea, vomiting, diarrhea, mucositis, infection and Graft Versus Host Disease development, need for intensive care, and 12-month mortality were recorded. RH states were evaluated during treatment.
RH developed in 78% of patients treated with HSCT. Pre-transplantation PGSGA score, frequency of vomiting, and development of infection were higher in patients with RH (p < 0.05). The patients had a mean weight loss of 2.9% after transplantation. Pre-transplantation, 88% of patients were well-nourished (PGSGA 0-3), post-transplantation, 70% of patients were moderately undernourished (PGSGA 4-8), and 30% were severely malnourished (PGSGA ≥ 9). While total protein and albumin decreased after transplantation, CRP increased (p < 0.05). According to multivariate logistic regression analysis, infection (95% CI: 1.375-61.379, p = 0.022) and pre-transplant PGSGA (95% CI: 1.035-45.454, p = 0.046) independently affect RH development.
RH was detected at a high rate in patients treated with HSCT. Elevated risk of malnutrition before transplantation, frequency of vomiting, and development of infection were determined as factors affecting RH development.
再喂养低磷血症(RH)发生在长时间未进食后开始喂养时。造血干细胞移植(HSCT)是治疗血液恶性肿瘤的有效方法之一。由于疾病的病理和治疗的影响,血液系统恶性肿瘤常伴有营养障碍。本研究旨在通过确定接受 HSCT 治疗的患者中 RH 的发生频率来确定影响因素。
本研究为前瞻性随机研究,共纳入 50 例首次接受 HSCT 的患者。研究对患者进行了 22 天的随访,包括移植前 7 天和移植后 14 天。随访期间,记录了 Scored Patient-Generated Subjective Global Assessment(PG-SGA)评分、体重变化、恶心、呕吐、腹泻、黏膜炎、感染和移植物抗宿主病(GVHD)发展、需要重症监护以及 12 个月死亡率等数据。在治疗期间评估 RH 状态。
HSCT 治疗患者中,78%发生 RH。RH 患者移植前 PG-SGA 评分、呕吐频率和感染发生率较高(p<0.05)。患者移植后平均体重减轻 2.9%。移植前,88%的患者营养良好(PG-SGA 0-3),移植后 70%的患者中度营养不良(PG-SGA 4-8),30%的患者严重营养不良(PG-SGA≥9)。移植后总蛋白和白蛋白降低,CRP 升高(p<0.05)。多因素 logistic 回归分析显示,感染(95%CI:1.375-61.379,p=0.022)和移植前 PG-SGA(95%CI:1.035-45.454,p=0.046)是 RH 发生的独立影响因素。
HSCT 治疗患者 RH 发生率较高。移植前营养不良风险增加、呕吐频率高、感染发生是影响 RH 发生的因素。